Ansamycin: Difference between revisions

217 bytes added ,  13 years ago
no edit summary
(Created page with ' Ansamycins is a family of secondary metabolites that show antimicrobial activity against many gram-positive and some gram-negative bacteria <ref>{{cite journal...')
 
'''Ansamycins''' is a family of secondary metabolites that show antimicrobial activity against many gram-positive and some gram-negative bacteria and includes various compounds among which: streptovaricins and rifamycins <ref>{{cite journal |author=Wehrli, W.; Staehelin, M. |journal=Bacteriol. Rev. |title=Actions of the rifamycins |journal=Bacteriol Rev. |volume=35 |pages=290 |year=1971}}</ref> and includes various compounds among which: streptovaricins and rifamycins. In addition, these compounds demonstrated antiviral activity towards bacteriophages and poxviruses. They are named ansamycins—ansaansamycins—''ansa'' from the Latin for handle—because of their unique structure which comprises of an aromatic moiety bridged by an aliphatic chain. <ref>{{cite journal |author=Prelog, V.; Oppolzer, W. |journal=Helv. Chim. Acta. |title=Ansamycine,Rifamycins. eine4. neuartigeAnsamycins, Klassea vonnovel mikrobiellenclass Stoffwechselproduktenof |journal=Helv.microbial Chim.metabolism Actaproducts |volume=56 |pages=2279 |year=1973}}</ref>. The main difference between various derivatives of ansamycins is the aromatic moiety, which can be a naphthalene ring or a naphthoquinone ring as in rifamycin and naphthomycin. <ref>{{cite journal |author=Balerna, M.; Keller-Schierlein, W.; Martius, C.; Wolf, H.; Zähner, H. |journal=Arch. Mikrobiol. |title=Metabolic products of microorganisms. 72. Naphthomycin, an antimetabolite of vitamin K |volume=65 |pages=303 |year=1969}}</ref>.
Another variation comprises of benzene or a benzoquinone ring system as in geldanamycin or ansamitocin. Ansamycins were first discovered in 1959 by Sensi et al from ''Amycolatopsis mediterranei'', an Actinomycete.<ref>{{cite journal |author=Sensi, P.; Margalith, P.; Timbal, M. T. |journal=Ed. Sci. |title=Rifomycin, a new antibiotic; preliminary report |volume=14 |pages=146 |year=1959}}</ref> Rifamycins are a subclass of ansamycins with high potency against mycobacterial activity. This resulted in their wide use in the treatment of tuberculosis, leprosy, and AIDS-related mycobacterial infections.<ref>{{cite journal |author=Floss, H. G.; Yu, T. |journal=Curr. Opin. Chem. Biol. |title=Lessons from the rifamycin biosynthetic gene cluster |volume=3 |pages=592 |year=1999}}</ref> Since then various analogues have been isolated from other prokaryotes.
 
== References ==
16

edits